Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, KF Larson, JG Ripoll, KJ Andersen… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, KF Larson, JG Ripoll, KJ Andersen… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
…, KF Larson, JG Ripoll, KJ Andersen… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
…, KF Larson, JG Ripoll, KJ Andersen… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
Convalescent plasma for infectious diseases: historical framework and use in COVID-19
…, SE Baker, KF Larson, BM Murphy, KJ Andersen… - Clinical Microbiology …, 2021 - Elsevier
Convalescent plasma has emerged as a promising therapeutic agent for patients with
coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being …
coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being …
SARS-CoV-2 serologic assays dependent on dual-antigen binding demonstrate diverging kinetics relative to other antibody detection methods
…, KJ Andersen, BM Murphy, J Harring… - Journal of clinical …, 2021 - Am Soc Microbiol
Longitudinal studies assessing durability of the anti-severe acute respiratory syndrome
coronavirus 2 (anti-SARS-CoV-2) humoral immune response have generated conflicting results. …
coronavirus 2 (anti-SARS-CoV-2) humoral immune response have generated conflicting results. …
Sex differences in paediatric airway anatomy
New Findings What is the central question of this study? Are sex difference in the central
airways present in healthy paediatric patients? What is the main finding and its importance? In …
airways present in healthy paediatric patients? What is the main finding and its importance? In …
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma
…, AJ Clayburn, KF Larson, JG Ripoll, KJ Andersen… - medRxiv, 2021 - medrxiv.org
Background The United States (US) Expanded Access Program (EAP) to COVID-19
convalescent plasma was initiated in response to the rapid spread of severe acute respiratory …
convalescent plasma was initiated in response to the rapid spread of severe acute respiratory …
Recruitment strategy for potential COVID-19 convalescent plasma donors
KJ Andersen, SA Klassen… - Mayo Clinic …, 2020 - mayoclinicproceedings.org
Coronavirus disease 2019 (COVID-19) represents a pandemic and global health crisis. In the
first wave of the disease in the United States, COVID-19 was diagnosed in approximately 2 …
first wave of the disease in the United States, COVID-19 was diagnosed in approximately 2 …